PortfoliosLab logoPortfoliosLab logo
LEA vs. CI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LEA vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lear Corporation (LEA) and Cigna Corporation (CI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LEA achieves a 20.65% return, which is significantly higher than CI's 4.02% return. Over the past 10 years, LEA has underperformed CI with an annualized return of 4.66%, while CI has yielded a comparatively higher 9.39% annualized return.


LEA

1D
-2.86%
1M
-1.72%
YTD
20.65%
6M
18.11%
1Y
54.07%
3Y*
2.77%
5Y*
-2.87%
10Y*
4.66%

CI

1D
0.35%
1M
-0.53%
YTD
4.02%
6M
4.58%
1Y
-8.71%
3Y*
2.93%
5Y*
5.74%
10Y*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LEA vs. CI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LEA
Lear Corporation
20.65%24.86%-31.17%16.40%-30.70%16.20%16.90%14.38%-29.29%35.23%
CI
Cigna Corporation
4.02%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%

Correlation

The correlation between LEA and CI is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Nov 9, 2009

0.33

The correlation between LEA and CI shifts across timeframes, from 0.16 (3 years) to 0.33 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LEA:

$7.05B

CI:

$74.74B

EPS

LEA:

$9.98

CI:

$23.59

PE Ratio

LEA:

13.69

CI:

12.00

PEG Ratio

LEA:

1.11

CI:

0.69

PS Ratio

LEA:

0.31

CI:

0.27

PB Ratio

LEA:

2.18

CI:

1.77

Total Revenue (TTM)

LEA:

$23.52B

CI:

$277.94B

Gross Profit (TTM)

LEA:

$1.26B

CI:

$19.38B

EBITDA (TTM)

LEA:

$1.20B

CI:

$10.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LEA vs. CI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LEA
LEA Risk / Return Rank: 8383
Overall Rank
LEA Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
LEA Sortino Ratio Rank: 8484
Sortino Ratio Rank
LEA Omega Ratio Rank: 8080
Omega Ratio Rank
LEA Calmar Ratio Rank: 8383
Calmar Ratio Rank
LEA Martin Ratio Rank: 8282
Martin Ratio Rank

CI
CI Risk / Return Rank: 3030
Overall Rank
CI Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
CI Sortino Ratio Rank: 2929
Sortino Ratio Rank
CI Omega Ratio Rank: 2828
Omega Ratio Rank
CI Calmar Ratio Rank: 3131
Calmar Ratio Rank
CI Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LEA vs. CI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lear Corporation (LEA) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LEACIDifference
Sharpe ratioReturn per unit of total volatility

+1.92

Sortino ratioReturn per unit of downside risk

+2.62

Omega ratioGain probability vs. loss probability

1.29

0.98

+0.31

Calmar ratioReturn relative to maximum drawdown

2.86

-0.33

+3.19

Martin ratioReturn relative to average drawdown

6.91

-0.59

+7.50

LEA vs. CI - Sharpe Ratio Comparison

The current LEA Sharpe Ratio is 1.66, which is higher than the CI Sharpe Ratio of -0.26. The chart below compares the historical Sharpe Ratios of LEA and CI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LEA vs. CI - Drawdown Comparison

The maximum LEA drawdown since its inception was -64.51%, smaller than the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for LEA and CI.


Loading charts...

Drawdown Indicators


LEACIDifference

Max Drawdown

Largest peak-to-trough decline

-64.51%

-84.34%

+19.83%

Max Drawdown (1Y)

Largest decline over 1 year

-18.98%

-26.54%

+7.56%

Max Drawdown (3Y)

Largest decline over 3 years

-49.42%

-32.10%

-17.32%

Max Drawdown (5Y)

Largest decline over 5 years

-57.83%

-32.10%

-25.73%

Max Drawdown (10Y)

Largest decline over 10 years

-64.51%

-42.47%

-22.04%

Current Drawdown

Current decline from peak

-24.02%

-20.02%

-4.00%

Average Drawdown

Average peak-to-trough decline

-19.83%

-18.82%

-1.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.85%

14.71%

-6.86%

Volatility

LEA vs. CI - Volatility Comparison

Lear Corporation (LEA) has a higher volatility of 8.63% compared to Cigna Corporation (CI) at 8.10%. This indicates that LEA's price experiences larger fluctuations and is considered to be riskier than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LEACIDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.63%

8.10%

+0.53%

Volatility (6M)

Calculated over the trailing 6-month period

24.64%

18.89%

+5.75%

Volatility (1Y)

Calculated over the trailing 1-year period

32.76%

33.34%

-0.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.05%

28.44%

+5.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.35%

30.77%

+4.58%

Dividends

LEA vs. CI - Dividend Comparison

LEA's dividend yield for the trailing twelve months is around 2.25%, more than CI's 2.17% yield.


PositionTTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
2.17%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
LEA
Lear Corporation
2.25%2.69%3.25%2.18%2.48%0.97%0.64%2.19%2.28%1.13%0.91%0.81%

Financials

LEA vs. CI - Financials Comparison

This section allows you to compare key financial metrics between Lear Corporation and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
5.82B
68.49B
(LEA) Total Revenue
(CI) Total Revenue
Values in USD except per share items

LEA vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between Lear Corporation and Cigna Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%2.0%4.0%6.0%8.0%10.0%12.0%14.0%2022202320242025202600
Portfolio components
LEA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lear Corporation reported a gross profit of 0.00 and revenue of 5.82B. Therefore, the gross margin over that period was 0.0%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a gross profit of 0.00 and revenue of 68.49B. Therefore, the gross margin over that period was 0.0%.

LEA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lear Corporation reported an operating income of 0.00 and revenue of 5.82B, resulting in an operating margin of 0.0%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported an operating income of 2.36B and revenue of 68.49B, resulting in an operating margin of 3.4%.

LEA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lear Corporation reported a net income of 172.30M and revenue of 5.82B, resulting in a net margin of 3.0%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cigna Corporation reported a net income of 1.65B and revenue of 68.49B, resulting in a net margin of 2.4%.


Frequently Asked Questions


LEA and CI have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LEA has higher volatility (8.63%) compared to CI (8.10%). In terms of maximum drawdown, LEA dropped -64.51% vs CI's -84.34%.

LEA currently has the higher Sharpe Ratio (1.66 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LEA and CI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer